This article summarizes recent analyst ratings for several NASDAQ-listed stocks, including Akero Therapeutics, Alumis, Amneal Pharmaceuticals, BRP Inc., Amplitude, and SoundHound AI. Read more...

Recent analyst reports show optimism for several companies, including Apogee Therapeutics, Avadel Pharmaceuticals, and Nvidia, with potential upside for investors. Read more...

This week's analyst activity includes price target adjustments for Portland General Electric, Neumora Therapeutics, Microchip Technology, ICON Public, and MongoDB. Read more...

Analyst ratings shift for major companies like Disney and HP, while HPE reports impressive revenue growth despite cash flow concerns. Plus, updates on Installed Building Products, MeridianLink, and Sunrun. Read more...

A roundup of recent analyst ratings and price target adjustments for companies like NetApp, Lexicon Pharmaceuticals, Medpace Holdings, and more. Plus, a look at Nvidia vs. Broadcom in the AI space. Read more...

Recent financial news includes Magnolia Private Wealth acquiring a stake in Meta, analysts rating MarketAxess "Hold," and Mizuho forecasting upside for PENN Entertainment. Read more...

Several stocks have seen recent target price adjustments by analysts. This article summarizes the latest ratings and price target changes for Owens Corning, AES, ON, Fulgent Genetics, and Rexford Industrial Realty. Read more...

A look at recent stock movements in the tech and medical sectors, highlighting insider buying in Sunrun, a price target reduction for GigaCloud, and disappointing earnings from Syndax. Read more...

Recent stock market activity includes changes in holdings for Wingstop, increased short interest in Alto Ingredients and Amalgamated Financial, and analyst upgrades for Okta and Roivant Sciences. Read more...

Citigroup mistakenly credited a client with $81 trillion, while China aims for 5% economic growth despite trade tensions with the US. This article examines both stories. Read more...

A roundup of recent stock activity for several tech companies, including CyberArk, Align Technology, Allegro MicroSystems, Globavend, Summit State Bank, and TWFG, showing a mix of investor sentiment. Read more...

Recent analyst reports show mixed outlooks for Kimbell Royalty Partners, Sempra, Myriad Genetics, and Okta, with revised price targets and ratings. Read more...

A look at recent stock market activity, including analyst ratings for Okta, a short interest update for Adicet Bio, and comparisons of SEALSQ vs. Kopin and Primega Group vs. Tutor Perini. Read more...

A roundup of recent stock market activity, including analyst ratings for Titan America, Astrana Health, and On Holding AG, plus movement in GreenPower Motor and ImmunityBio stocks. Read more...

Recent analyst reports have adjusted price targets for several stocks, including Fortrea, Docebo, and Silence Therapeutics. We examine these changes and their potential impact. Read more...

Citigroup faces scrutiny after an $81 trillion error and fluctuating analyst ratings for stocks like Abbott Labs, Bio-Techne, Thermo Fisher, Mettler-Toledo, and Okta. Read more...

Raymond James adjusts its price target for Viant Technology and revises earnings estimates for Elemental Altus Royalties, impacting investor outlook. Read more...

Barclays faces a mix of challenges and opportunities, from IT outages and customer compensation to analyst upgrades and a former boss's legal fight over Epstein links. This article summarizes recent news surrounding the bank. Read more...

Recent analyst reports have adjusted price targets and ratings for several companies, including Talen Energy, Sunnova Energy, GitLab, Kohl's, and ThredUp. Read more...

A summary of recent analyst ratings adjustments for various companies, including Agilysys, GitLab, Sphere Entertainment, Talos Energy, and Okta, highlighting potential upsides and downsides. Read more...